Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CANINE PARVOVIRUS ATTENUATED
Merial Animal Health Limited
QI07AD01
CANINE PARVOVIRUS ATTENUATED
Unknown
Lyophilisate for suspension
POM
Canine
Canine parvovirus vaccine
Immunological - Live Vaccine
Authorised
2004-11-03
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican P. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml dose of vaccine contains: Freeze-dried pellet: Attenuated canine parvovirus >10 4.9 CCID 50 Excipients q.s. 1 dose For full list of excipients, see section 6.1. CCID 50 = 50% cell culture infective dose. 3 PHARMACEUTICAL FORM Lyophilisate for suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and puppies from 8 weeks of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of dogs from 8 weeks of age to prevent clinical signs and to reduce mortality and viral excretion caused by canine parvovirosis infection. Onset of immunity: 7 days after primary vaccination Duration of immunity: 2 years. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 25/05/2012_ _CRN 7012354_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS: The CPV vaccine strain of Eurican P may be shed from vaccinated animals for a number of days following vaccination. However, due to the absence of pathogenicity of the strain, it is not necessary to keep vaccinated animals separated from non-vaccinated animals. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS: In the case of accidental self injection, seek medical advice immediately and show this package insert or the label to the physican. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) In rare cases, slight and transient pain may be apparent at the time of injection, which regresses within 2 hours. In exceptional circumstances a hypersensitivity Read the complete document